Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus.
复制标题
是不是狼疮?SLE风险概率指数(SLERPI):一个简单的,临床友好的基于机器学习的模型,以帮助诊断系统性红斑狼疮。
DOI:
10.1136/annrheumdis-2020-219069
复制
发表时间:
2021-06
影响因子:
27.4
通讯作者:
Bertsias GK
中科院分区:
文献类型:
--
作者:
Adamichou C;Genitsaridi I;Nikolopoulos D;Nikoloudaki M;Repa A;Bortoluzzi A;Fanouriakis A;Sidiropoulos P;Boumpas DT;Bertsias GK
Diagnostic reasoning in systemic lupus erythematosus (SLE) is a complex process reflecting the probability of disease at a given timepoint against competing diagnoses. We applied machine learning in well-characterised patient data sets to develop an algorithm that can aid SLE diagnosis. From a discovery cohort of randomly selected 802 adults with SLE or control rheumatologic diseases, clinically selected panels of deconvoluted classification criteria and non-criteria features were analysed. Feature selection and model construction were done with Random Forests and Least Absolute Shrinkage and Selection Operator-logistic regression (LASSO-LR). The best model in 10-fold cross-validation was tested in a validation cohort (512 SLE, 143 disease controls). A novel LASSO-LR model had the best performance and included 14 variably weighed features with thrombocytopenia/haemolytic anaemia, malar/maculopapular rash, proteinuria, low C3 and C4, antinuclear antibodies (ANA) and immunologic disorder being the strongest SLE predictors. Our model produced SLE risk probabilities (depending on the combination of features) correlating positively with disease severity and organ damage, and allowing the unbiased classification of a validation cohort into diagnostic certainty levels (unlikely, possible, likely, definitive SLE) based on the likelihood of SLE against other diagnoses. Operating the model as binary (lupus/not-lupus), we noted excellent accuracy (94.8%) for identifying SLE, and high sensitivity for early disease (93.8%), nephritis (97.9%), neuropsychiatric (91.8%) and severe lupus requiring immunosuppressives/biologics (96.4%). This was converted into a scoring system, whereby a score >7 has 94.2% accuracy. We have developed and validated an accurate, clinician-friendly algorithm based on classical disease features for early SLE diagnosis and treatment to improve patient outcomes.
登录
查看更多内容
影响因子:
2.6
作者:
Feng, X.;Zou, Y.;Sun, L.
通讯作者:
Sun, L.
影响因子:
5.5
作者:
Bortoluzzi, Alessandra;Scire, Carlo Alberto;Govoni, Marcello
通讯作者:
Govoni, Marcello
影响因子:
27.4
作者:
Gergianaki, Irini;Fanouriakis, Antonis;Bertsias, George K.
通讯作者:
Bertsias, George K.
影响因子:
3.9
作者:
Nikolopoulos, Dionysis S.;Kostopoulou, Myrto;Fanouriakis, Antonis
通讯作者:
Fanouriakis, Antonis
影响因子:
4.4
作者:
Donner-Banzhoff, Norbert
通讯作者:
Donner-Banzhoff, Norbert